Physician Lead, MedTAC

Job Summary * (In three or four sentences summarize the job’s purpose and primary focus.)

Under the direction of the Physician Director, Resource Stewardship, the goal of this position is to ensure right care, right place, right time, right clinician regarding medication therapy. Scope of work includes supporting region wide ambulatory appropriateness of services with a strong emphasis on Medication Treatment Appropriateness Committee (MedTAC) initiatives (i.e., pharmacy). Responsible for the development, implementation, and monitoring of needed MedTAC initiatives to improve efficiency of ambulatory utilization of services and enhance affordability and quality of care. Goals are reached through collaboration with key stakeholders such as partners in clinical departments and pharmacy. Provides positive influence to Chiefs and TSPMG physicians to follow evidence-based utilization guidelines and appropriateness of care criteria to achieve MedTAC goals.

Major Responsibilities/Essential Functions * (In order of importance, list primary job duties this position is responsible for achieving. Each statement should relate to a result or objective.)

• Collaborating with Physician Director of Resource Stewardship (RS) and Physician Lead of RS, MedTAC Committee, Pharmacy staff in monthly meetings (and unscheduled meetings as needed).
• Responsible for reviewing quarterly MedTAC data and SharePoint MedTAC monthly data updates.
• Attending the monthly Leads Meeting to share MedTAC metrics status and ongoing performance improvement projects.
• Communicating directly to adult medicine providers, Leads, Chief of Adult Medicine, Chief of Family Medicine, appropriate Quality Leads and Primary Care AMD regarding MedTAC initiatives and performance improvement projects.
• Responsible for creating strategies to drive process improvement in MedTAC initiatives including both scored and monitored metrics.

a. Reducing hospitalization and death from poorly controlled asthma through Albuterol Refills metric.

· Single Maintenance and Rescue Therapy (SMART) for asthma care.

b. Promoting appropriate antibiotic prescribing and reducing over-prescribing in cases where viral URI or bronchitis is present.

c. Reducing the use of High-Risk Medications in the Elderly.

· Reducing Skeletal Muscle Relaxer (SMR) prescribing in members age 65 or greater.

· Reducing use of Anticholinergic medication use in members age 65 or greater.

· Reducing Poly-CNS drug prescribing in members age 65 or greater.

· Focus on De-Prescribing strategies to reduce Polypharmacy risks in our older members.

• Focus on providing affordable care through judicious use of prescribing in adult medicine.

· Avoiding Brand Named Drugs When Generics are Available (BWGA): Focus on S.A.F.E prescribing (considering generics as Safe, Affordable, Effective, and Equivalent to their generic counterparts).

· Appropriate prescribing (and de-prescribing) of SGLT-2 drugs.

· Appropriate prescribing (and de-prescribing) of DPP4 drugs.

· Appropriate prescribing (and de-prescribing) of GLP-1 drugs.

• Focus on safe prescribing of High-Risk adult medications.

· Limited amount dispensed for first prescription of BZD and Non-BZD sedative hypnotic drugs.

· Limited amount dispensed for refills of BZD and Non-BZD sedative hypnotic drugs and reduced chronicity of prescribing.

· Limited amount dispensed for first prescription of OPIOD drugs.

· Limited amount dispensed for refills of OPIOID drugs, reduced chronicity of prescribing, and promoting writing for 50 MME or less.

· Avoiding OPIOD and BZD co-prescribing.

· Avoiding OPIOD and Gabapentinoid co-prescribing.

• Focus on Medication Adherence for as it relates to diabetes medications, statins, and ACEI/ARB prescribing.
• Focus on Medication Reconciliation.

· Promoting 90 days + 3 refills.

· Promoting Mail-order pharmacy use.

• Promoting Statin Use in Diabetic Patients.